Characterization of private mutations in the spike protein of SARS-CoV-2 correlates with viral prevalence
Shuo Wang(Nanjing Medical University), Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention), Yuhan Ding(Jiangsu Provincial Center for Disease Control and Prevention), Xiaojuan Zhu(East China University of Science and Technology), Shuo Ning(Jiangsu Provincial Center for Disease Control and Prevention), Jingxin Li(Jiangsu Provincial Center for Disease Control and Prevention), Heng Rong(Jiangsu Provincial Center for Disease Control and Prevention), Tina Wu(Yale University), Qiao Qiao(First Hospital of China Medical University), Ziyang Hao(Nanjing Medical University), Yiyue Ge(Jiangsu Provincial Center for Disease Control and Prevention), Kangchen Zhao(Jiangsu Provincial Center for Disease Control and Prevention), Liguo Zhu(Jiangsu Provincial Center for Disease Control and Prevention)
Cited by 1
Related Papers
Co-infection with respiratory pathogens among COVID-2019 cases
|Virus Research|2020|637
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391
A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China, 2007: Further Evidence of Person-to-Person Transmission
|Clinical Infectious Diseases|2011|268
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|Signal Transduction and Targeted Therapy|2021|204